A clinical trial (called “BEAT-Lupus”) has found that using a combination of two biologic treatments, rituximab and belimumab, may be more effective than using rituximab alone in patients who have not responded well to other treatment. They also found that people with a particular indicator in their blood may respond better to this combined treatment.
You can read more about the trial and what they found in our article here: lupusuk.org.uk/an-indicator...